Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
- PMID: 16105859
- DOI: 10.1152/ajpendo.00529.2004
Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
Abstract
To assess mechanisms for postprandial hyperglycemia, we used a triple-isotope technique ([\3-(3)H]glucose and [(14)C]bicarbonate and oral [6,6-dideutero]glucose iv) and indirect calorimetry to compare components of glucose release and pathways for glucose disposal in 26 subjects with type 2 diabetes and 15 age-, weight-, and sex-matched normal volunteers after a standard meal. The results were as follows: 1) diabetic subjects had greater postprandial glucose release (P<0.001) because of both increased endogenous and meal-glucose release; 2) the greater endogenous glucose release (P<0.001) was due to increased gluconeogenesis (P<0.001) and glycogenolysis (P=0.01); 3) overall tissue glucose uptake, glycolysis, and storage were comparable in both groups (P>0.3); 4) glucose clearance (P<0.001) and oxidation (P=0.004) were reduced, whereas nonoxidative glycolysis was increased (P=0.04); and 5) net splanchnic glucose storage was reduced by approximately 45% (P=0.008) because of increased glycogen cycling (P=0.03). Thus in type 2 diabetes, postprandial hyperglycemia is primarily due to increased glucose release; hyperglycemia overcomes the effects of impaired insulin secretion and sensitivity on glucose transport, but intracellular defects persist so that pathways of glucose metabolism are abnormal and glucose is shunted away from normal sites of storage (e.g., liver and muscle) into other tissues.
Similar articles
-
Pathways for glucose disposal after meal ingestion in humans.Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E716-25. doi: 10.1152/ajpendo.00365.2002. Epub 2002 Dec 10. Am J Physiol Endocrinol Metab. 2003. PMID: 12475753
-
Metabolic fate of plasma glucose during hyperglycemia in impaired glucose tolerance: evidence for further early defects in the pathogenesis of type 2 diabetes.Am J Physiol Endocrinol Metab. 2009 Mar;296(3):E440-4. doi: 10.1152/ajpendo.90505.2008. Epub 2009 Jan 13. Am J Physiol Endocrinol Metab. 2009. PMID: 19141691
-
Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes.Am J Physiol Endocrinol Metab. 2004 Dec;287(6):E1049-56. doi: 10.1152/ajpendo.00041.2004. Epub 2004 Aug 10. Am J Physiol Endocrinol Metab. 2004. PMID: 15304374
-
Inhibition of glucagon secretion.Adv Pharmacol. 2005;52:151-71. doi: 10.1016/S1054-3589(05)52008-8. Adv Pharmacol. 2005. PMID: 16492545 Review.
-
[Physiopathological fundamentals of type 2 diabetes].Rev Prat. 1999 Jan 1;49(1):22-9. Rev Prat. 1999. PMID: 9926712 Review. French.
Cited by
-
The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes.Diabetes. 2012 Sep;61(9):2349-58. doi: 10.2337/db11-1701. Epub 2012 Jun 20. Diabetes. 2012. PMID: 22721966 Free PMC article. Clinical Trial.
-
Absorption patterns of meals containing complex carbohydrates in type 1 diabetes.Diabetologia. 2013 May;56(5):1108-17. doi: 10.1007/s00125-013-2852-x. Epub 2013 Feb 23. Diabetologia. 2013. PMID: 23435829
-
Lactate activation of α-cell KATP channels inhibits glucagon secretion by hyperpolarizing the membrane potential and reducing Ca2+ entry.Mol Metab. 2020 Dec;42:101056. doi: 10.1016/j.molmet.2020.101056. Epub 2020 Jul 28. Mol Metab. 2020. PMID: 32736089 Free PMC article.
-
Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies.Molecules. 2018 May 29;23(6):1304. doi: 10.3390/molecules23061304. Molecules. 2018. PMID: 29844263 Free PMC article.
-
Glucagon-mediated impairments in hepatic and peripheral tissue nutrient disposal are not aggravated by increased lipid availability.Am J Physiol Endocrinol Metab. 2009 May;296(5):E1172-8. doi: 10.1152/ajpendo.90821.2008. Epub 2009 Feb 10. Am J Physiol Endocrinol Metab. 2009. PMID: 19208853 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical